Bladder Cancer Prevention Program
Aiming to raise awareness on the prevention and treatment of bladder cancer, PASYKAF, in May 2019, joined forces with the Cyprus Urological Association and a group of people who have experienced bladder cancer.
More specifically, the Program aims to minimize incidents of bladder cancer by creating awareness of early signs and symptoms, defend patients’ rights and to improve their quality of life.
What actions does PASYKAF take?
In May 2019, within the framework of Bladder Cancer Awareness Month, PASYKAF announced the establishment of a Bladder Cancer Patient Support Group at a press conference held at the European University Cyprus in Nicosia.
The Group includes people who have experienced bladder cancer, Urologists – Andrologists working in the public and private sector as well as Oncologists.
The Association works closely with the members of the Group to identify the needs of people previously affected by bladder cancer and find ways to improve their quality of life.
What does PASYKAF offer you?
PASYKAF provides the following services to patients, the public and organised groups in cities, communities or their workplace free of charge:
- Ιnformation material on the prevention, early diagnosis and treatment of bladder cancer
- Defending patients’ rights and improving their quality of life
- Updates on bladder cancer from Associate Urologists
- Lectures and presentations
- Training to health professionals
For information, call 77 77 19 86 or email email@example.com
The bladder is a balloon-shaped organ that stores urine produced by the kidneys and then released through the urethra when urinating.
What causes bladder cancer?
The most important risk factor for bladder cancer is smoking. Smokers are 4 to 7 times more likely to develop bladder cancer. Other risk factors include chronic inflammation, chronic catheterisation, occupational exposure to chemicals used in the textile, dye, paint, leather and rubber industries, and long-term infections.